Added to YB: 2025-01-24
Pitch date: 2024-12-10
VTRS [bullish]
Viatris Inc.
+34.23%
current return
Author Info
No bio for this author
Company Info
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Market Cap
$18.2B
Pitch Price
$11.91
Price Target
20.00 (+25%)
Dividend
3.04%
EV/EBITDA
7.70
P/E
-5.04
EV/Sales
2.25
Sector
Pharmaceuticals
Category
value
Viatris Inc. - $VTRS
VTRS: 5 straight Qs of growth, completed divestitures, reduced leverage. $2.3B FCF, 50% to shareholders. 2025: $1.6B-$1.9B for returns (10.5-12.5% yield). $3.28 EPS by FY26, 6x P/E = $20 stock. 27% 2-yr IRR. Not 'melting ice cube'. 3% topline growth target, HSD-LDD% EPS growth. Catalysts: 2025 buybacks, improved financials 2H25, 2026-27 clinical data.
Read full article (4 min)